⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27645872 | 0.80 | — | — | |
| SCHEMBL22731942 | 0.78 | — | — | |
| SCHEMBL29586735 | 0.76 | CA2 (0.50) | — | |
| SCHEMBL19629162 | 0.75 | CA2 (0.38) | — | |
| SCHEMBL1058394 | 0.75 | — | — | |
| SCHEMBL4660402 | 0.74 | CA2 (0.58) | — | |
| SCHEMBL1334849 | 0.72 | — | — | |
| SCHEMBL3613047 | 0.72 | — | — | |
| SCHEMBL1058395 | 0.70 | — | — | |
| SCHEMBL3403934 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 100 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1642588-A2 | Mimetics of interleukin-8 and methods of using them in the prevention, treatment, diagnosis, and ameliorization of symptoms of a disease | Chemokine Therapeutics Corporation (CA) | 2006-04-05 | — | — | EP | claimed |
| US-20240218034-A1 | MACROCYCLIC MODULATORS OF DISEASE ASSOCIATED PROTEIN MISFOLDING AND AGGREGATION | RESQ BIOTECH (GR) | 2024-07-04 | — | — | US | disclosed |
| US-11858974-B2 | Macrocyclic modulators of disease associated protein misfolding and aggregation | RESQ BIOTECH (GR) | 2024-01-02 | — | — | US | disclosed |
| EP-4218784-A2 | MACROCYCLIC MODULATORS OF DISEASE ASSOCIATED PROTEIN MISFOLDING AND AGGREGATION | National Hellenic Research Foundation (GR) | 2023-08-02 | — | — | EP | disclosed |
| US-20200140506-A1 | MACROCYCLIC MODULATORS OF DISEASE ASSOCIATED PROTEIN MISFOLDING AND AGGREGATION | NATIONAL HELLENIC RESEARCH FOUNDATION (GR) | 2020-05-07 | — | — | US | disclosed |
| US-9290751-B2 | LPL variant therapeutics | Hayden, Michael R. (CA) | 2016-03-22 | — | — | US | disclosed |
| US-20150030581-A1 | LPL VARIANT THERAPEUTICS | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2015-01-29 | — | — | US | disclosed |
| US-8268778-B2 | Flavivirus NS5A proteins for the treatment of HIV | UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) | 2012-09-18 | — | — | US | disclosed |
| EP-2432497-A1 | USE OF LIPOPROTEIN LIPASE (LPL) IN THERAPY | Amsterdam Molecular Therapeutics (AMT) IP B.V. (NL) | 2012-03-28 | — | — | EP | disclosed |
| US-20110269692-A1 | ALPHA-FETOPROTEIN PEPTIDES AND USES THEREOF | ALBANY MEDICAL COLLEGE | 2011-11-03 | — | — | US | disclosed |
| EP-1200117-A2 | LIPOPROTEIN LIPASE (LPL) VARIANT THERAPEUTICS | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2002-05-02 | — | — | EP | disclosed |
| WO-2001090361-A2 | MODULATION OF INFLAMMATION BY PROTEASE-TREATED MCP-3 CHEMOKINE | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2001-11-29 | — | — | WO | disclosed |
| US-6319498-B1 | AMYLOIDOGENIC PROTEIN, OR FRAGMENT THEREOF, MODIFIED WITH CIS-DECALIN GROUP, CHOLANOYL STRUCTURE, CHOLYL GROUP, DIETHYLENETRIAMINEPENTAACETYL GROUP, MENTHOXYACETYL GROUP, FLUORESCEIN-CONTAINING GROUP, OR N-ACETYLNEURAMINYL GROUP | PRAECIS PHARMACEUTICALS INCORPORATED | 2001-11-20 | — | — | US | disclosed |
| WO-2001085196-A2 | CXCR4 ANTAGONIST TREATMENT OF HEMATOPOIETIC CELLS | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2001-11-15 | — | — | WO | disclosed |
| WO-2001076615-A2 | CXCR4 AGONIST TREATMENT OF HEMATOPOIETIC CELLS | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2001-10-18 | — | — | WO | disclosed |
| US-6303567-B1 | FOR DIAGNOSIS AND THERAPY OF AMYLOIDOGENIC DISEASES SUCH AS ALZHEIMER'S DISEASE | PRAECIS PHARMACEUTICALS, INC . | 2001-10-16 | — | — | US | disclosed |
| US-6277826-B1 | CONSISTING OF D-LEUCINE, D-PHENYLALANINE AND D-VALINE; PEPTIDE IS MODIFIED AT THE AMINO-TERMINUS, THE CARBOXY-TERMINUS, OR BOTH WITH AN AMIDE OR A HYDROXY GROUP | PRAECIS PHARMACEUTICALS, INC. | 2001-08-21 | — | — | US | disclosed |
| WO-2001000220-A2 | LIPOPROTEIN LIPASE (LPL) VARIANT THERAPEUTICS | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2001-01-04 | — | — | WO | disclosed |
| US-5985242-A | PEPTIDE OF 3 TO 5 D-AMINO ACIDS; MAY BE MODIFIED AT AMINO-AND/OR CARBOXY TERMINUS; FOR TREATMENT OF AMYLOIDOSIS, ALZHEIMER'S DISEASE | PRAECIS PHARMACEUTICALS, INC. (US) | 1999-11-16 | — | — | US | disclosed |
| US-5854204-A | Aβ peptides that modulate β-amyloid aggregation | PRAECIS PHARMACEUTICALS, INC. (US) | 1998-12-29 | — | — | US | disclosed |